Antiviral chemistry & chemotherapy · 1993 · 20 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular VirologyStructure-activity RelationshipsAntiretroviral TherapyAntiviral AgentsAntiviral ImmunityAntiviral PharmacologyEnzyme InhibitionStructure-activity Relationship AnalysisActivitiesAntiviral Drug MechanismsAntiviral Mechanisms Of ActionAntiviral Natural ProductsAntiviral Structure-activity RelationshipsAntiviral TherapeuticsConcentrationViral Fusion Inhibitors
A novel series of 2-indolinones with in vitro anti-HIV (human immunodeficiency virus) activity is described. Two structurally related compounds, 1, 3,3-(4- N-methyl-1,2,5,6-tetrahydropyridylmethyl)-1- phenyl-2-indolinone, and 2, its 4- N-methylpiperidinylmethyl analogue (Fig. 1), formed the basis of a structure-activity study. The synthesis of approximately 50 analogues and their respective activities vs. HIV are presented. Both 1 and 2 were effective inhibitors of HIV(IIIb) in cell protection assays with IC 90 values of 4.4 and 14.9μM (2.2 and 7.9μg ml −1 ), respectively. In the same concentration range, 1 and 2 also inhibit syncytia formation. These compounds represent a novel class of anti-HIV agents which appear to act by inhibiting virus-dependent cell fusion.
23
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Noel A. Roberts, Joseph A. Martin, Derek Kinchington et al. · Science · 1990 · 925 citations